Total planned funding: $171,387,042
Allocations
Countries/Regions
India | $171,387,042 |
Organizational Types
Unknown | $85,891,687 |
NGO | $45,033,011 |
Own Agency | $23,219,036 |
University | $9,650,000 |
Multi-lateral Agency | $3,516,808 |
Private Contractor | $1,659,000 |
FBO | $1,600,000 |
Host Country Government Agency | $410,200 |
Other USG Agency | $407,300 |
Program Areas
Governance and Systems | $57,395,424 |
Prevention | $45,807,627 |
Care | $25,014,953 |
Management and Operations | $17,555,748 |
Testing | $10,937,772 |
Treatment | $10,247,726 |
Budget Codes
OHSS: Health Systems Strengthening | $30,632,370 |
HVOP: Sexual Prevention: Other Sexual Prevention | $23,096,109 |
HVSI: Strategic Information | $21,384,939 |
HVMS: Management and Operations | $17,555,748 |
HBHC: Care: Adult Care and Support | $17,458,987 |
HVCT: Testing: HIV Testing and Counseling | $10,937,772 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $10,577,405 |
HTXS: Treatment: Adult Treatment | $9,811,231 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $5,831,064 |
HLAB: Laboratory Infrastructure | $5,378,115 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $5,003,396 |
HKID: Care: Orphans and Vulnerable Children | $3,733,913 |
HVTB: Care: TB/HIV | $3,550,020 |
HMBL: Biomedical Prevention: Blood Safety | $1,299,653 |
PDTX: Treatment: Pediatric Treatment | $413,018 |
PDCS: Care: Pediatric Care and Support | $272,033 |
HTXD: Treatment: ARV Drugs | $23,477 |
Top Partner Programs
Not Available:
$84,844,198
Countries/Regions
FHI 360:
$18,415,228
Countries/Regions
USG Aggregated Agencies:
$14,723,883
Countries/Regions
Voluntary Health Services:
$8,030,000
Countries/Regions